David Hunter

Prof. David Hunter

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in The Lancet
Verified
Journal Article
Closed access
DHDavid Hunter
David Hunter
SBSita Bierma-Zeinstra
Sita Bierma-Zeinstra

1 March 2014 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
TMT.E. McAlindon
T.E. McAlindon
RBR.R. Bannuru
R.R. Bannuru
MSM.C. Sullivan
M.C. Sullivan
NAN.K. Arden
N.K. Arden
FBFrancis Berenbaum
Francis Berenbaum
MUM. Underwood
M. Underwood

1 August 2011 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
DHDavid Hunter
David Hunter
AGA. Guermazi
A. Guermazi
GLG.H. Lo
G.H. Lo
AGA.J. Grainger
A.J. Grainger
PCPhilip Conaghan
Philip Conaghan
FRF.W. Roemer
F.W. Roemer

1 November 2020 in The Lancet
Verified
Journal Article
Closed access
DHDavid Hunter
David Hunter
LMLyn March
Lyn March
MCMabel Chew
Mabel Chew

1 February 2014 in Best Practice & Research Clinical Rheumatology
Verified
Journal Article
Closed access
VJVictoria L. Johnson
Victoria L. Johnson
DHDavid Hunter
David Hunter

25 March 2016 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
BDBhushan R. Deshpande
Bhushan R. Deshpande
JKJeffrey N. Katz
Jeffrey N. Katz
DSDaniel H. Solomon
Daniel H. Solomon
EYEdward H. Yelin
Edward H. Yelin
DHDavid Hunter
David Hunter
ELElena Losina
Elena Losina
Objective: The prevalence of symptomatic knee osteoarthritis (OA) has been increasing over the past several decades in the US, concurrent with an aging population and the growing obesity epidemic. We quantify the impact of these factors on the number of persons with symptomatic knee OA in the early decades of the 21st century.Methods: We calculated the prevalence of clinically diagnosed symptomatic knee OA from the National Health Interview Survey 2007–2008 and derived the proportion with advanced disease (defined as Kellgren/Lawrence grade 3 or 4) using the Osteoarthritis Policy Model, a validated simulation model of knee OA. Incorporating contemporary obesity rates and population estimates, we calculated the number of persons living with symptomatic knee OA.Results: We estimate that approximately 14 million persons had symptomatic knee OA, with advanced OA comprising more than half of those cases. This includes more than 3 million persons of racial/ethnic minorities (African American, Hispanic, and other). Adults younger than 45 years of age represented nearly 2 million cases of symptomatic knee OA and individuals between 45 and 65 years of age comprised 6 million more cases.Conclusion: More than half of all persons with symptomatic knee OA are younger than 65 years of age. As many of these younger persons will live for 3 decades or more, there is substantially more time for greater disability to occur, and policymakers should anticipate health care utilization for knee OA to increase in the upcoming decades. These data emphasize the need for the deployment of innovative prevention and treatment strategies for knee OA, especially among younger persons.